New malaria center for Johns Hopkins

Malaria research has been underfunded for decades. Now, a $100 million donation to Johns Hopkins University should allow much-needed progress on vaccines.

Written byDan Ferber
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

URBANA, ILLINOIS Malaria kills more than two million people per year and causes sickness in 300–500 million. But despite the continuing toll, funding for malaria research, treatment and prevention has been scarce and two decades of efforts to develop a vaccine have so far been unsuccessful. The situation grew so dire that the Institute of Medicine concluded in a 1996 report that "the outlook for malaria control is grim."

So it was big news when an anonymous donor gave a $100 million on 7 May to the Bloomberg School of Public Health at Johns Hopkins University in Baltimore for a new research center devoted entirely to understanding and stopping malaria.

That funding is the latest of several initiatives to combat the disease, including a new research push from the National Institutes of Health — also announced 7 May — to boost malaria, tuberculosis and HIV research, $115 million from the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems